Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease

Overview of attention for article published in New England Journal of Medicine, May 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 25 news outlets
twitter: 151 X users
patent: 25 patents

facebook: 15 Facebook pages
googleplus: 3 Google+ users
reddit: 2 Redditors

Readers on

mendeley: 224 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 25 patents that reference this research output.

RNAi constructs for inhibiting ASGR1 expression and methods of use thereof

Grant US-12723248-B1

United States of America

01 Sep 2026

RNAI constructs for inhibiting PNPLA3 expression and methods of use thereof

Grant US-12674166-B2

United States of America

07 Jul 2026

ASGPR-binding compounds for the degradation of extracellular proteins

Grant US-12667620-B2

United States of America

30 Jun 2026

ASGPR-binding compounds for the degradation of extracellular proteins

Grant US-12622972-B2

United States of America

12 May 2026

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 21 additional patents.